cost to sale of biological assets. Financial Cost Financial cost in Quarter 2/2019 was Baht 8.5 Million decreased by Baht 1.3 Million or 13.1% from Q2/2018 mainly from bank loan repayment in 2018. Net
Transaction In Quarter 2/2018, the company recorded Baht 22.2 million from gain on sales of deposits for land, Baht 3.9 million from gain on changes in fair value less costs to sell biological asset and Baht
and internal control of subsidiaries improvement. Other Transaction In Quarter 3/2018, the company recorded Baht 4.0 million from gain on changes in fair value less costs to sell biological asset and
essential for economic development and sustainability. Applying science to Thailand?s resource abundance and biological diversity will bring about better quality of life and economic sustainable development
มนุษยห์นัไปกิน อาหารขยะมากขึน สุขภาพแยล่ง ผึงสูญพันธุ/์ อพยพยา้ยถิน อนุสัญญาวา่ด้วยความหลากหลายทางชวีภาพ Convention on Biological Diversity (CBD) กรอบงานคณุหมงิ-มอนทรอิอล (Kunming- Montreal Global
finance loan or bank guarantee. As a result, the Company has been running the business by its existing cash flow in the Company and having to place the cash in the full amount as a guarantee to the Bank in
from financial institutions. As a result, the Company has been running the business by its working capital and wages from the owners, including support from distributors result in the Company and
, respectively. The Company still has been running the business by its working capital, so there is no financial cost burden. Please be informed accordingly. Sincerely yours, (Mr. Pitsanu Vichitcholchai) Chief
Co., Ltd. (“GWM”), running the business of kidney cleanser and medical supplies manufacturing and distribution, which is decrease from the same quarter of the previous years for 0.47 million baht
for intermediaries or their employees to use advance information on clients? trading orders of securities or derivatives to execute their own orders before clients? (front running), or disclose such